Home/Filings/4/0001181431-13-030881
4//SEC Filing

Wright Paul 4

Accession 0001181431-13-030881

CIK 0001279695other

Filed

May 27, 8:00 PM ET

Accepted

May 28, 11:46 AM ET

Size

9.5 KB

Accession

0001181431-13-030881

Insider Transaction Report

Form 4
Period: 2013-05-16
Wright Paul
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2013-05-27+917917 total
  • Award

    Stock Option (Right to Buy)

    2012-11-13+37,50037,500 total
    Exercise: $0.00Exp: 2019-11-12Common Stock (37,500 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $1.38Exp: 2018-02-23Common Stock (2,300,000 underlying)
    2,300,000
  • Common Stock

    (indirect: By Macquarie Super Manager)
    44,666
Footnotes (4)
  • [F1]The prices reported are stated in Australian dollars.
  • [F2]The reported securities are held by the Macquaire Super Manager for the account of the Reporting Person.
  • [F3]On November 13, 2012, the board of directors approved the grant of these options subject to shareholder approval. Such shareholder approval was received on May 16, 2013. The stock options vest and become exercisable in three equal tranches om 12/31/13, 12/31/14 and 12/31/15.
  • [F4]1,400,000 options vest in equal traunches over three years subject to continued employment at the time of vesting. 500,000 of the options vested upon the company entering into a material partnership/licensing agreement with Siemens Healthcare Diagnostics, Inc. on September 9, 2011. 400,000 options vest upon CE marketing or first regulatory approval in the United States of the final test to which the partnership/licensing arranagement relates, subject to continued employment at the time of vesting.

Issuer

UNIVERSAL BIOSENSORS INC

CIK 0001279695

Entity typeother

Related Parties

1
  • filerCIK 0001514822

Filing Metadata

Form type
4
Filed
May 27, 8:00 PM ET
Accepted
May 28, 11:46 AM ET
Size
9.5 KB